Clincosm LogoSign in Get a demo

chronic spontaneous urticaria

Showing 1 - 25 of 46
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Spontaneous Urticaria Trial in Dublin (ABT Online Programme, Delayed Control group)

Suspended
  • Chronic Spontaneous Urticaria
  • ABT Online Programme
  • Delayed Control group
  • Dublin, Ireland
    St James's Hospital
Oct 25, 2023

Chronic Spontaneous Urticaria Trial in Canada, United States (Oral EP262, Placebo)

Recruiting
  • Chronic Spontaneous Urticaria
  • Oral EP262
  • Placebo
  • Birmingham, Alabama
  • +7 more
Oct 5, 2023

Healthy Participants, Chronic Spontaneous Urticaria Trial in Anniston (AK006, Placebo)

Recruiting
  • Healthy Participants
  • Chronic Spontaneous Urticaria
  • Anniston, Alabama
    Site 601-001 Healthy Volunteer Clinical Research Unit
Oct 2, 2023

Xolair® in Pediatric Chronic Spontaneous Urticaria in China

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • Xolair
  • (no location specified)
Sep 19, 2023

Chronic Spontaneous Urticaria Trial (Remibrutinib, Placebo to remibrutinib, Placebo to omalizumab)

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • (no location specified)
Sep 20, 2023

Adenosine Deaminase and Immunoglobulin E in Chronic Spontaneous

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • Adenosine deaminase serum level
  • IgE antibodies serum level
  • (no location specified)
Aug 7, 2023

Allergic Disease, Chronic Spontaneous Urticaria, Chronic Inducible Urticaria Trial in Seongnam-si, Suwon-si, Seoul (YH35324,

Recruiting
  • Allergic Disease
  • +3 more
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
  • +4 more
Jul 24, 2023

Urticaria, Chronic Spontaneous Urticaria, Chronic Idiopathic Urticaria Trial (Povorcitinib, Placebo)

Not yet recruiting
  • Urticaria
  • +5 more
  • (no location specified)
Jul 6, 2023

Chronic Spontaneous Urticaria, Chronic Urticaria, Idiopathic Trial in Copenhagen (omalizumab 300 mg every four weeks, omalizumab

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • Chronic Urticaria, Idiopathic
  • omalizumab 300 mg every four weeks
  • omalizumab 300 mg every six weeks
  • Copenhagen, Copenhagen N, Denmark
    Department of Dermatology, Bispebjerg Hospital
Jun 21, 2023

Chronic Spontaneous Urticaria Trial (LOU064)

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • (no location specified)
Mar 21, 2023

Chronic Spontaneous Urticaria Trial in Worldwide (Ligelizumab)

Terminated
  • Chronic Spontaneous Urticaria
  • Birmingham, Alabama
  • +254 more
Jan 31, 2023

Chronic Spontaneous Urticaria Trial in Germany, United States (CDX-0159, Normal Saline)

Completed
  • Chronic Spontaneous Urticaria
  • Birmingham, Alabama
  • +13 more
Jan 24, 2023

Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa Trial in Canada, Germany, United States

Recruiting
  • Atopic Dermatitis
  • +5 more
    • Scottsdale, Arizona
    • +61 more
    Jan 24, 2023

    Chronic Spontaneous Urticaria Trial in Worldwide (rilzabrutinib, )

    Recruiting
    • Chronic Spontaneous Urticaria
    • Caba, Buenos Aires, Argentina
    • +66 more
    Jan 20, 2023

    Chronic Spontaneous Urticaria Trial in Worldwide (Benralizumab, Placebo and Benralizumab)

    Active, not recruiting
    • Chronic Spontaneous Urticaria
    • Benralizumab
    • Placebo and Benralizumab
    • Scottsdale, Arizona
    • +39 more
    Jan 16, 2023

    Chronic Spontaneous Urticaria Trial (LOU064 (blinded), )

    Not yet recruiting
    • Chronic Spontaneous Urticaria
    • LOU064 (blinded)
    • placebo
    • (no location specified)
    Dec 23, 2022

    Chronic Spontaneous Urticaria Trial in Worldwide (Ligelizumab, Omalizumab, Placebo)

    Completed
    Has Results
    • Chronic Spontaneous Urticaria
    • Ligelizumab
    • +2 more
    • Gilbert, Arizona
    • +160 more
    Dec 12, 2022

    Chronic Spontaneous Urticaria Trial in Hungary, United States (barzolvolimab, Matching Placebo)

    Recruiting
    • Chronic Spontaneous Urticaria
    • barzolvolimab
    • Matching Placebo
    • Birmingham, Alabama
    • +44 more
    Dec 8, 2022

    Chronic Spontaneous Urticaria Trial in Jacksonville (Nucala)

    Recruiting
    • Chronic Spontaneous Urticaria
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Nov 30, 2022

    Chronic Spontaneous Urticaria Trial in Japan (TAS5315 Dose 1, TAS5315 Dose 2, TAS5315 Dose 3)

    Recruiting
    • Chronic Spontaneous Urticaria
    • TAS5315 Dose 1
    • +5 more
    • Fukuoka, Japan
    • +4 more
    Aug 15, 2022

    Chronic Spontaneous Urticaria Trial in Worldwide (Ligelizumab, Omalizumab, Placebo)

    Completed
    • Chronic Spontaneous Urticaria
    • Ligelizumab
    • +2 more
    • Birmingham, Alabama
    • +182 more
    Aug 5, 2022

    Chronic Spontaneous Urticaria Trial in Worldwide (Tezepelumab Dose 1, Tezepelumab Dose 2, Omalizumab)

    Recruiting
    • Chronic Spontaneous Urticaria
    • Tezepelumab Dose 1
    • +3 more
    • Birmingham, Alabama
    • +81 more
    Aug 4, 2022

    Chronic Spontaneous Urticaria Trial in Worldwide (LOU064)

    Active, not recruiting
    • Chronic Spontaneous Urticaria
    • Litchfield Park, Arizona
    • +68 more
    Jul 19, 2022

    Healthy Study Participants, Chronic Spontaneous Urticaria Trial in Sofia (UCB8600, Placebo)

    Terminated
    • Healthy Study Participants
    • Chronic Spontaneous Urticaria
    • Sofia, Bulgaria
      Up0086 001
    Jul 15, 2022

    Chronic Spontaneous Urticaria Trial in Japan (LOU064)

    Recruiting
    • Chronic Spontaneous Urticaria
    • Nagoya, Aichi, Japan
    • +11 more
    Jul 14, 2022